MarketBeat reports a Hold consensus for Molina Healthcare stock
Published on 10/08/2026 at 16:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- MarketBeat reported a Hold consensus from 17 analysts on October 7, 2026, with 11 Hold ratings.
- Molina Healthcare raised adjusted 2026 earnings guidance to at least USD 5.25 per share in its second-quarter update.
- The Lang & Schwarz price was EUR 171.45 on October 8, 2026, down 1.47 percent from EUR 174.00.
- Molina Healthcare is scheduled to report third-quarter 2026 results on October 21, 2026.
On October 7, 2026, MarketBeat reported a Hold consensus for Molina Healthcare from 17 analysts, including 11 Holds, two Sells, three Buys and one Strong Buy. Molina Healthcare stock was trading at EUR 171.45 at Lang & Schwarz on October 8, 2026 at 4:35 p.m. CEST, down 1.47 percent from the prior close of EUR 174.00.
Three dates frame the story
On July 22, 2026, Molina Healthcare reported second-quarter adjusted earnings of USD 1.51 per share against a USD 1.39 consensus estimate, while revenue reached USD 10.87 billion, according to MarketBeat.
On September 2, 2026, Molina Healthcare announced that it would release third-quarter results on October 21, 2026, according to Zonebourse.
On October 7, 2026, MarketBeat put the average 12-month price target at USD 202.44 and described the analyst split as Hold, giving the current event a quantified market reference.
What does the guidance mean?
Molina's second-quarter update kept full-year 2026 premium revenue guidance at approximately USD 42 billion and raised adjusted earnings guidance by USD 0.25 to at least USD 5.25 per share, according to Fortune. The increase reflected first-half Medicaid performance, while Marketplace guidance was reduced by USD 1.50 per share because of unfavorable member acuity mix and prior-year items.
That split explains the cautious analyst stance. The company said its second-quarter adjusted pre-tax margin was 1.00 percent and its consolidated medical care ratio was 92.20 percent, while full-year premium revenue guidance remained unchanged at USD 42 billion.
Next date is October 21
Zacks identifies October 21, 2026 as Molina Healthcare's confirmed next earnings release date. Its current consensus calls for USD 0.73 in earnings per share for the quarter ending in September 2026, compared with USD 1.51 in the second quarter.
Price reflects the earnings wait
Molina Healthcare had a market capitalization of USD 10.1 billion as of October 8, 2026, while its NYSE 52-week range was USD 121.06 to USD 244.89. The gap between the current euro quote and the upcoming report keeps the October 21 date central to the stock's near-term narrative.
The further course of trading is shown by the continuously updated real-time quote of Molina Healthcare stock.
Molina Healthcare stock at a glance
- Company: Molina Healthcare, Inc.
- ISIN: US60855R1005
- Ticker: MOH
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 4:35 p.m. CEST: EUR 171.45
- Change versus prior close: minus 1.47 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 174.00
- Market capitalization: USD 10.1 billion as of October 8, 2026
- 52-week range: USD 121.06-244.89 as of October 8, 2026
- Sector / Industry: Healthcare / Medical - Healthcare Plans
- Index membership: S&P 500
- Next earnings date: October 21, 2026
Market context: Market report S&P 500.
